GNGBF (Getinge AB) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GNGBF Getinge AB GNGBF
76 GF Score
Price $22.49
GF Value $20.70
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Getinge AB FFO?

FFO (Funds from operations) only applies to REITs.

GNGBF
76GF Score
Getinge AB GNGBF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Getinge AB (GNGBF) Overvalued in 2026?

Based on GuruFocus' analysis, Getinge AB stock appears to be overvalued. The current stock price of $22.49 is trading 8.6% above its estimated GF Value™ of $20.70. GuruFocus considers Getinge AB to be Fairly Valued.

Key valuation signals for GNGBF:

  • FFO:
  • GF Value™: $20.70 vs. price of $22.49 (8.6% above fair value)
  • GF Score™: 76/100 with 10 warning signs

No single metric tells the full story. See the GNGBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Getinge AB Business Description

Address Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, 417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
76GF Score

Get the complete analysis for GNGBF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.49
Price
$20.70
GF Value